SI-BONE Names Jeryl (“Jeri”) Hilleman to Board of Directors

    NEXT STORY
    Adaptive Biotechnologies and Collaborators to Present Data from More Than 25 clonoSEQ® Abstracts at ASH 2019 Demonstrating Clinical Relevance of Standardized, Accurate MRD Testing for Blood Cancer Patients
    PREV STORY
    Spero Reports Preliminary Findings from Phase 1 Clinical Trial of SPR720 and Announces Plans to Advance Program into Proof-of-Concept Clinical Trial in Patients with NTM Pulmonary Disease
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Kura Oncology to Report Fourth Quarter and Full Year 2017 Financial Results

    SAN DIEGO, March 05, 2018 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq:KURA), a clinical-stage ...

    author_avatar
    NASDAQ Market News

    Reminder: Investor Conference Call Today July 25, 2019 Management to Provide Details on Generex Up-list and 1:1 Stock Dividend

    author_avatar
    NASDAQ Market News

    Plus Therapeutics, Inc. Announces Closing of $15 Million Underwritten Public Offering

    author_avatar
    NASDAQ Market News